首页
OALib 期刊
OALib 预印
快速投稿通道
排名
新闻
我的图书馆
常见问题
关于我们
关注我们+
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
Biomedical & Life Sciences
Business & Economics
Chemistry & Materials Science
Computer Science & Communications
Engineering
Medicine & Healthcare
Physics & Mathematics
Social Sciences & Humanities
LinkedIn (OALib Group)
LinkedIn (OALib Company Page)
Facebook
Twitter
全部
标题
作者
关键词
摘要
OALib Journal期刊
ISSN: 2333-9721
费用:99美元
投递稿件
为什么选择我们?
>>
- 开源期刊
- 同行审议
- 快速出刊
- 终身存储
- 免费检索
- 免费推广
- 更多...
- 搜索引擎
-
ISSN Print: 2059-0105
ISSN Online:
主页:
https://www.nature.com/npjvaccines
分享:
Go
Rabies-based vaccine induces potent immune responses against Nipah virus
Recent advances in the production of recombinant glycoconjugate vaccines
Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice
A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus
OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Plague vaccine: recent progress and prospects
Turning the corner on therapeutic cancer vaccines
Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules
Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigen
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal Bacillus anthracis spore inhalation challenge
A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
A recombinant vesicular stomatitis-based Lassa fever vaccine elicits rapid and long-term protection from lethal Lassa virus infection in guinea pigs
From therapeutic antibodies to immune complex vaccines
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein
Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
Selection and evaluation of an efficient method for the recovery of viral nucleic acids from complex biologicals
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations
Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties
Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development
Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development
Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation
VaxArray potency assay for rapid assessment of “pandemic” influenza vaccines
Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica
Vaccination route can significantly alter the innate lymphoid cell subsets: a feedback between IL-13 and IFN-γ
System immunology-based identification of blood transcriptional modules correlating to antibody responses in sheep
Generation of therapeutic antisera for emerging viral infections
Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge
A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate
Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness
A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice
A combination of TLR-4 agonist and saponin adjuvants increases antibody diversity and protective efficacy of a recombinant West Nile Virus antigen
AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
Malaria vaccine candidate based on Duffy-binding protein elicits strain transcending functional antibodies in a Phase I trial
A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting
LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection
Antibody targeting of a specific region of Pfs47 blocks Plasmodium falciparum malaria transmission
Gallid herpesvirus 3 SB-1 strain as a recombinant viral vector for poultry vaccination
A new era in cytomegalovirus vaccinology: considerations for rational design of next-generation vaccines to prevent congenital cytomegalovirus infection
The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial
Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates
Go